Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals (Q41263208)

28 September 2017

title

Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals (English)

1 reference

28 September 2017

Howard SG

1

1 reference

28 September 2017

Feigenbaum JJ

series ordinal

2

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

28 September 2017

published in

Biochemical Pharmacology

1 reference

28 September 2017

volume

53

1 reference

28 September 2017

issue

1

1 reference

28 September 2017

page(s)

103-110

1 reference

GAMMA-HYDROXYBUTYRATE, A NORMAL BRAIN METABOLITE.

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Gammahydroxybutyrate: an endogenous regulator of energy metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Involvement of the nerve flow in the release of extragranular dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Effect of -hydroxybutyrate on the release of monoamines from the rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Release of monoamines from the striatum and hypothalamus: Effect of γ‐hydroxybutyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Long-term depression in striatal dopamine release monitored by in vivo voltammetry in free moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Electrochemistry in vivo: Monitoring dopamine release in the brain of the conscious, freely moving rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Release of newly synthesized 3H-dopamine in the striatum: an adaptation of the push-pull cannula method to awake restrained and anesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: Evidence for both pre- and post-synaptic inhibition of catecholamine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Effects of gamma-butyrolactone, amphetamine, and haloperidol in mice differing in sensitivity to alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Glutamate-evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Reversal of the anaesthetic action of sodium gamma-hydroxybutyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

An adaptation of the push-pull cannula method to study the in vivo release of (3H)dopamine synthesized from (3H)tyrosine in the cat caudate nucleus: effects of various physical and pharmacological treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Systemic phencyclidine administration is associated with increased dopamine, GABA, and 5-HIAA levels in the dorsolateral striatum of conscious rats: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

In vivo characterisation of extracellular dopamine, GABA and acetylcholine from the dorsolateral striatum of awake freely moving rats by chronic microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

The effect of halothane dose on striatal dopamine: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Importance of the calcium content infused during microdialysis for the effects induced by D2 agonists on the release of dopamine in the striatum of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Striatal extracellular dopamine in conscious vs. anesthetized rats: effects of chloral hydrate anesthetic on responses to drugs of different classes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Effects of Chloral Hydrate, ?-Butyrolactone, and Equithesin on the Efflux of Dopamine and 5-Hydroxytryptamine Metabolites into Cerebroventricular Perfusates of Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Changes in brain chemistry produced by dopaminergic agents: in vivo electrochemical monitoring reveals opposite changes in anesthetized vs unanesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

Gamma hydroxybutyrate is not a GABA agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00664-8

10.1016/S0006-2952(96)00664-8

7 January 2021

Identifiers

DOI

1 reference

28 September 2017

1 reference